1. Market Research
  2. > Pharmaceutical
  3. > Pathology Market Trends
  4. > Autoimmune Disease Therapeutics to 2016

Autoimmune Disease Therapeutics to 2016

  • May 2012
  • -
  • Greystone Research Associates

As a group, autoimmune diseases represent one of the most intractable families of conditions facing medical science. The complexities and genetic underpinnings of the human immune response result in a set of disease targets that are at once physiologically ubiquitous and highly individualized. Until recently, autoimmune disease patients were given little hope for an effective treatment. But the convergence an of improved understanding of autoimmune disease mechanisms and the availability of recombinant cytokines has led to systemic treatments that, while not devoid of side effects, have demonstrated the ability to control autoimmune reactions in a significant number of patients. A number of potentially important pipeline drugs hold the promise of future improvements in outcomes for autoimmune disease patients. This study analyzes current autoimmune therapeutics and assesses the next-generation of candidates and their probable impact on treatment options and the competitive landscape.

Highlights

• Analyzes current therapeutic options for autoimmune diseases, and evaluates emerging therapeutic candidates and assesses their commercial potential
• Assesses existing and evolving immune disease mechanisms and treatment strategies
• Analyzes more than two dozen existing and emerging autoimmune disease targets and target-specific therapeutic drug products
• Evaluates regional and global opportunities for autoimmune therapeutics
• Provides market data and forecasts for six major autoimmune disease segments to 2016

Table Of Contents

Autoimmune Disease Therapeutics to 2016
Executive Summary

Autoimmune Therapeutics Segment Dynamics

Sector Market Dynamics
Patient Demographics and Growth
Chronic Disease and Self-administration
Managed Care and Prescribing Trends
Factors Limiting Growth
Industry Alignment and Competitive Landscape

Autoimmune Therapeutic Market Assessments

Arthritis
Disease Forms and Immune Mechanisms
Therapeutic Strategies
Disease Demographics and Growth
Key Approved Therapies
Development-stage Candidate Assessment
Market Factors
Commercial Outlook and Forecasts

Crohn's Disease
Disease Incidence and Demographics
Current Generation Treatment Options
Therapies in Development
Market Factors
Commercial Outlook and Forecasts

Diabetes
Restoring Islet Cell Function
Therapies in Development
Commercial Outlook and Forecasts

Lupus
The Ongoing Unmet Need
Pipeline Candidates - A Ray of Hope
Market Factors
The Potential for a Lupus-specific Therapy
Commercial Outlook and Forecasts

Multiple Sclerosis
Disease Mechanisms and Therapeutic Strategies
The Market Opportunity
Competitive Landscape
Development-stage Candidate Assessment
Market Factors
Commercial Outlook and Forecasts

Psoriasis
Therapeutic Options and Expanded Indications
Prescribing Trends and Drug Efficacy
Market Sector Factors
Development-stage Candidate Assessment
Commercial Outlook and Forecasts

Market Factors
Risk Factors
Clinical Trial Factors
Product Issues

Autoimmune Therapeutics - Company Profile

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 8 Major Markets 2016-2026

Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 8 Major Markets 2016-2026

  • $ 6 172
  • Industry report
  • February 2016
  • by Black Swan Analysis Ltd

Summary Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ulcerative Colitis in 8 Major Markets Ulcerative Colitis (UC) is an inflammatory bowel disease (IBD) causing chronic inflammation ...

Epiomic Epidemiology Series: Addison%s Disease Forecast in 10 Major Markets 2016-2026

Epiomic Epidemiology Series: Addison%s Disease Forecast in 10 Major Markets 2016-2026

  • $ 6 172
  • Industry report
  • March 2016
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Addison’s Disease in 10 Major Markets Addison's disease (AD) is a chronic and rare endocrinal disorder, caused by destruction of ...

Autoimmune Disease Diagnostics Market Analysis By Product (Systemic, Localized, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ankylosing Spondylitis) And Segment Forecasts To 2020

Autoimmune Disease Diagnostics Market Analysis By Product (Systemic, Localized, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ankylosing Spondylitis) And Segment Forecasts To 2020

  • $ 4 700
  • Industry report
  • May 2016
  • by Grand View Research

Global autoimmune disease diagnostics market is expected to reach USD 14.17 billion by 2020. Growing prevalence of autoimmune diseases coupled with the presence of favorable government initiatives such ...


Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US and China - Forecast

  • May 2016
    19 pages
  • Endocrine, Nutr...  

    Hormone  

  • United States  

    China  

View report >

Pathology Description in the US

  • April 2016
    75 pages
  • Cancer  

  • United States  

View report >

Pathology Description in the US

  • April 2016
    54 pages
  • Cancer  

  • United States  

View report >

Vaccine Industry

2 months ago

Related Market Segments :

Autoimmune Disease

ref:plp2012

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.